Last updated on July 2020

Safety Tolerability and Efficacy of Selonsertib Firsocostat and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH)

Brief description of study

The primary objective of this study is to evaluate the safety and tolerability of selonsertib, firsocostat, cilofexor, fenofibrate and/or Vascepa in adults with nonalcoholic fatty liver disease (NAFLD) or nonalcoholic steatohepatitis (NASH).

Clinical Study Identifier: NCT02781584

Find a site near you

Start Over

Florida Research Institute

Lakewood Ranch, FL United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.